1. Home
  2. FGEN vs CAPT Comparison

FGEN vs CAPT Comparison

Compare FGEN & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • CAPT
  • Stock Information
  • Founded
  • FGEN 1993
  • CAPT 2005
  • Country
  • FGEN United States
  • CAPT South Korea
  • Employees
  • FGEN N/A
  • CAPT N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • CAPT Blank Checks
  • Sector
  • FGEN Health Care
  • CAPT Finance
  • Exchange
  • FGEN Nasdaq
  • CAPT Nasdaq
  • Market Cap
  • FGEN 38.4M
  • CAPT 41.1M
  • IPO Year
  • FGEN 2014
  • CAPT N/A
  • Fundamental
  • Price
  • FGEN $10.56
  • CAPT $1.29
  • Analyst Decision
  • FGEN Strong Buy
  • CAPT
  • Analyst Count
  • FGEN 2
  • CAPT 0
  • Target Price
  • FGEN $146.50
  • CAPT N/A
  • AVG Volume (30 Days)
  • FGEN 66.4K
  • CAPT 183.0K
  • Earning Date
  • FGEN 08-11-2025
  • CAPT 01-01-0001
  • Dividend Yield
  • FGEN N/A
  • CAPT N/A
  • EPS Growth
  • FGEN N/A
  • CAPT N/A
  • EPS
  • FGEN N/A
  • CAPT N/A
  • Revenue
  • FGEN $7,346,000.00
  • CAPT $17,389,944.00
  • Revenue This Year
  • FGEN N/A
  • CAPT N/A
  • Revenue Next Year
  • FGEN N/A
  • CAPT N/A
  • P/E Ratio
  • FGEN N/A
  • CAPT N/A
  • Revenue Growth
  • FGEN N/A
  • CAPT 84.70
  • 52 Week Low
  • FGEN $4.50
  • CAPT $0.37
  • 52 Week High
  • FGEN $21.94
  • CAPT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 68.96
  • CAPT 46.91
  • Support Level
  • FGEN $9.05
  • CAPT $1.21
  • Resistance Level
  • FGEN $11.71
  • CAPT $1.31
  • Average True Range (ATR)
  • FGEN 0.77
  • CAPT 0.07
  • MACD
  • FGEN 0.32
  • CAPT -0.02
  • Stochastic Oscillator
  • FGEN 76.95
  • CAPT 36.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

Share on Social Networks: